Lindsay Rosenwald
   HOME

TheInfoList



OR:

Lindsay A. Rosenwald is an American
doctor Doctor or The Doctor may refer to: Personal titles * Doctor (title), the holder of an accredited academic degree * A medical practitioner, including: ** Physician ** Surgeon ** Dentist ** Veterinary physician ** Optometrist *Other roles ** ...
and
biotechnology Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used b ...
and life-sciences industry investor. and one of two co-founders and partners of Opus Point Partners, an asset management company that invests in the
healthcare Health care or healthcare is the improvement of health via the prevention, diagnosis, treatment, amelioration or cure of disease, illness, injury, and other physical and mental impairments in people. Health care is delivered by health profe ...
space, primarily in
biotechnology Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used b ...
. He has been a prolific founder of development stage biotech companies. Rosenwald has started many biotechnology companies who have over 100 licensed clinical-stage medicines. Many of those drugs were approved by the United States
Food and Drug Administration The United States Food and Drug Administration (FDA or US FDA) is a List of United States federal agencies, federal agency of the United States Department of Health and Human Services, Department of Health and Human Services. The FDA is respon ...
as well as in foreign countries. One medicine was approved for
Acute promyelocytic leukemia Acute promyelocytic leukemia (APML, APL) is a subtype of acute myeloid leukemia (AML), a cancer of the white blood cells. In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a ...
, a routinely fatal disease, that has cured many thousands of incurable patients over the last decade and continues that achievement today, marking a change to how this disease is treated. Another cancer drug developed by one of his start-up companies is today a near billion dollar-selling drug for prostate cancer. Additionally, that company was the first company to acquire approximately $1 billion after only phase 2 studies. Other drugs approved by the United States and many other countries include drugs for
schizophrenia Schizophrenia is a mental disorder characterized by continuous or relapsing episodes of psychosis. Major symptoms include hallucinations (typically hearing voices), delusions, and disorganized thinking. Other symptoms include social withdra ...
,
fibromyalgia Fibromyalgia (FM) is a medical condition defined by the presence of chronic widespread pain, fatigue, waking unrefreshed, cognitive symptoms, lower abdominal pain or cramps, and depression. Other symptoms include insomnia and a general hyp ...
,
obesity Obesity is a medical condition, sometimes considered a disease, in which excess body fat has accumulated to such an extent that it may negatively affect health. People are classified as obese when their body mass index (BMI)—a person's we ...
,
influenza Influenza, commonly known as "the flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms ...
, and
infant respiratory distress syndrome Infantile respiratory distress syndrome (IRDS), also called respiratory distress syndrome of newborn, or increasingly surfactant deficiency disorder (SDD), and previously called hyaline membrane disease (HMD), is a syndrome in premature infants c ...
.


Early life

Rosenwald graduated from
Abington Senior High School Abington Senior High School is a three-year co-educational high school in Abington, Pennsylvania, United States. The school was a two-year high school known as Abington South Campus from September 1964 until June 1983. In September 1983, Abingt ...
, located in southeast Pennsylvania, in 1973, and went on to graduate from
Pennsylvania State University The Pennsylvania State University (Penn State or PSU) is a Public university, public Commonwealth System of Higher Education, state-related Land-grant university, land-grant research university with campuses and facilities throughout Pennsylvan ...
with a major in Finance and Economy in 1977, graduating
Beta Gamma Sigma Beta Gamma Sigma () is the International Business Honor Society. Founded in 1913 at the University of Wisconsin, University of Illinois and the University of California, it has over 980,000 members, selected from more than 600 collegiate chapters ...
. Then he worked as an independent management consultant for health care companies from 1977 to 1979 before entering
Temple University Temple University (Temple or TU) is a public state-related research university in Philadelphia, Pennsylvania. It was founded in 1884 by the Baptist minister Russell Conwell and his congregation Grace Baptist Church of Philadelphia then called Ba ...
at their School of Medicine. After graduating from Temple in 1983, Rosenwald took an internship at Abington Medical Hospital and remained in private medical practice until 1986. At that time, he moved to Wall Street to serve as a physician/financial analyst, a specialized combination of fields which very few boasted at that time.


Career

In 1988 Lindsay A. Rosenwald became a managing director of corporate finance for D.H. Blair & Co., a privately owned investment firm headed by J. Morton ("Morty") Davis. D.H. Blair underwrote hundreds of companies, many in the biotechnology industry. Several D.H. Blair brokers were indicted for fraud and the firm was shut down. Rosenwald headed a team of three physician-financiers who searched in the medical community for the latest developments that could be marketed with the help of private investment. They got in touch with hospitals, medical schools, pharmaceutical companies, universities, scientific firms and research groups. In 1991, Rosenwald founded Paramount Bio Capital, where he dealt with fields of bioresearch and biotechnology. Since 1992, he became a NASD-member dealer. In 1995 Paramount Capital Investments LLC, a merchant and investment bank, was founded. Paramount Capital Asset Management, Inc., owned by Rosenwald, managed the investments of several funds specializing in the technology and biotechnology sectors, since 1994. Rosenwald also serves as a member of the Columbia-Presbyterian
Health Sciences The following outline is provided as an overview of and topical guide to health sciences: Health sciences are those sciences which focus on health, or health care, as core parts of their subject matter. Health sciences relate to multiple acad ...
Advisory Counsel. Rosenwald was number one in the 2002 edition of
Genetic Engineering News Mary Ann Liebert, Inc. is a privately held independent publishing company founded by its president (corporate title), president, Mary Ann Liebert, in 1980. The company publishes peer review, peer-reviewed academic journals, books, and trade magaz ...
' 100 Molecular Millionaires. Since 2002, Rosenwald was in the board of directors for Keryx Biopharmaceuticals, Inc., which he resigned in 2006 to devote more time to the biotechnology market. Cougar Biotechnology, another company founded by Rosenwald, was purchased by
Johnson & Johnson Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company i ...
in 2009 based solely on
abiraterone acetate Abiraterone acetate, sold under the brand name Zytiga among others, is a medication used to treat prostate cancer. Specifically it is used together with a corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) and metastatic ...
. This drug was not yet in phase III clinical trials for its application in
prostate cancer Prostate cancer is cancer of the prostate. Prostate cancer is the second most common cancerous tumor worldwide and is the fifth leading cause of cancer-related mortality among men. The prostate is a gland in the male reproductive system that sur ...
treatment and therapy, but was so promising that Johnson & Johnson bid & purchased the company in a "short-term merger" for approximately $1 billion. In addition to his activities which have provided capital and funding to many portfolio companies, Rosenwald also started the Rosenwald Foundation, a nonprofit organization which has provided millions of dollars to support various scientific and medical education institutions. In 2009, Rosenwald and Michael S. Weiss founded a new company called OpusPoint Partners. This company specializes in healthcare and life sciences investments and consulting. In October 2010, he invested in securities in National Holdings Corporation purchasing approximately 23.6% of NHC.


References

{{DEFAULTSORT:Rosenwald, Lindsay 1955 births Living people Smeal College of Business alumni Biotechnologists